Company intelligence / Profile preview

Delve Bio

San Francisco, California, United Statesdelve.bio ↗
Ownership
Private
Development stage
Commercial
01

Overview

Delve Bio’s flagship product "Delve Detect" is a commercially available metagenomic next-generation sequencing test for infectious disease diagnosis using cerebrospinal fluid. It can detect over 68,000 pathogens with a rapid turnaround time of 48 hours. Clinical studies have shown superior diagnostic yield compared to traditional methods; in one study involving over 4,800 patients with suspected CNS infection, the test identified pathogens in 14.4% of samples[5]. The platform also enables viral subtyping and phylogenetic classification from sequence data[1].

Therapeutic areas
Infectious Diseases
Modalities
Diagnostic testMetagenomic next-generation sequencing (mNGS)
Industry
Molecular Diagnostics
02

Partnerships

Exclusive in-license from University of California San Francisco for mNGS diagnostic platform technology

Beyond the preview

Go deeper on Delve Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Delve Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call